Edgewise Therapeutics Inc (EWTX)
34.50
+0.50
(+1.47%)
USD |
NASDAQ |
Nov 04, 16:00
34.50
0.00 (0.00%)
After-Hours: 20:00
Edgewise Therapeutics Total Assets (Quarterly): 531.65M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 531.65M |
| March 31, 2024 | 553.81M |
| December 31, 2023 | 340.04M |
| September 30, 2023 | 311.36M |
| June 30, 2023 | 330.62M |
| March 31, 2023 | 346.40M |
| December 31, 2022 | 367.10M |
| September 30, 2022 | 377.15M |
| Date | Value |
|---|---|
| June 30, 2022 | 257.40M |
| March 31, 2022 | 272.74M |
| December 31, 2021 | 285.23M |
| September 30, 2021 | 294.45M |
| June 30, 2021 | 303.49M |
| March 31, 2021 | 311.24M |
| December 31, 2020 | 131.14M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
131.14M
Minimum
Dec 2020
553.81M
Maximum
Mar 2024
334.26M
Average
311.36M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 706.36M |
| Vertex Pharmaceuticals Inc | 20.13B |
| Sarepta Therapeutics Inc | 3.424B |
| Regenxbio Inc | 569.38M |
| Entrada Therapeutics Inc | 581.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.17M |
| Shareholders Equity (Quarterly) | 510.47M |